Stock ELVN ENLIVEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/06/2024 BST 		5-day change 1st Jan Change
21.7 USD -1.45% Intraday chart for Enliven Therapeutics, Inc. +3.63% +56.79%
06-11 Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target MT
05-29 Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENLIVEN THERAPEUTICS, INC. Stock Enliven Therapeutics, Inc.
 1.02B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. Charts Enliven Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW